vs
帕可Bio（PACB）与STEM, INC.（STEM）财务数据对比。点击上方公司名可切换其他公司
STEM, INC.的季度营收约是帕可Bio的1.1倍（$47.1M vs $44.6M），STEM, INC.净利率更高（-33.9% vs -90.4%，领先56.5%），帕可Bio同比增速更快（13.8% vs -15.6%），过去两年STEM, INC.的营收复合增速更高（36.1% vs 7.3%）
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
该公司是一家公开上市的生物制药企业，总部位于加利福尼亚州纽瓦克，专注研发纯化人类神经干细胞，旨在治疗中枢神经系统疾病与瘫痪，其所研发的神经干细胞可分化为中枢神经系统的神经元、星形胶质细胞与少突胶质细胞这三大主要细胞类型。
PACB vs STEM — 直观对比
营收规模更大
STEM
是对方的1.1倍
$44.6M
营收增速更快
PACB
高出29.4%
-15.6%
净利率更高
STEM
高出56.5%
-90.4%
两年增速更快
STEM
近两年复合增速
7.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $44.6M | $47.1M |
| 净利润 | $-40.4M | $-16.0M |
| 毛利率 | 37.1% | 48.9% |
| 营业利润率 | -92.3% | -17.7% |
| 净利率 | -90.4% | -33.9% |
| 营收同比 | 13.8% | -15.6% |
| 净利润同比 | -1802.7% | 68.8% |
| 每股收益（稀释后） | $-0.11 | $-4.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PACBSTEM
| Q4 25 | $44.6M | $47.1M | ||
| Q3 25 | $38.4M | $38.2M | ||
| Q2 25 | $39.8M | $38.4M | ||
| Q1 25 | $37.2M | $32.5M | ||
| Q4 24 | $39.2M | $55.8M | ||
| Q3 24 | $40.0M | $29.3M | ||
| Q2 24 | $36.0M | $34.0M | ||
| Q1 24 | $38.8M | $25.5M |
净利润PACBSTEM
| Q4 25 | $-40.4M | $-16.0M | ||
| Q3 25 | $-38.0M | $-23.8M | ||
| Q2 25 | $-41.9M | $202.5M | ||
| Q1 25 | $-426.1M | $-25.0M | ||
| Q4 24 | $2.4M | $-51.1M | ||
| Q3 24 | $-60.7M | $-148.3M | ||
| Q2 24 | $-173.3M | $-582.3M | ||
| Q1 24 | $-78.2M | $-72.3M |
毛利率PACBSTEM
| Q4 25 | 37.1% | 48.9% | ||
| Q3 25 | 41.4% | 35.5% | ||
| Q2 25 | 36.9% | 33.4% | ||
| Q1 25 | -3.7% | 32.4% | ||
| Q4 24 | 25.6% | -4.4% | ||
| Q3 24 | 25.0% | 21.2% | ||
| Q2 24 | 16.5% | 27.6% | ||
| Q1 24 | 29.1% | -95.0% |
营业利润率PACBSTEM
| Q4 25 | -92.3% | -17.7% | ||
| Q3 25 | -101.1% | -33.6% | ||
| Q2 25 | -112.8% | -34.8% | ||
| Q1 25 | -1154.5% | -65.0% | ||
| Q4 24 | -390.1% | -84.4% | ||
| Q3 24 | -160.3% | -493.2% | ||
| Q2 24 | -488.3% | -1705.5% | ||
| Q1 24 | -209.6% | -267.0% |
净利率PACBSTEM
| Q4 25 | -90.4% | -33.9% | ||
| Q3 25 | -98.9% | -62.2% | ||
| Q2 25 | -105.4% | 527.8% | ||
| Q1 25 | -1146.8% | -76.9% | ||
| Q4 24 | 6.0% | -91.6% | ||
| Q3 24 | -151.9% | -506.3% | ||
| Q2 24 | -481.3% | -1712.6% | ||
| Q1 24 | -201.4% | -283.9% |
每股收益（稀释后）PACBSTEM
| Q4 25 | $-0.11 | $-4.40 | ||
| Q3 25 | $-0.13 | $-2.84 | ||
| Q2 25 | $-0.14 | $-1.79 | ||
| Q1 25 | $-1.44 | $-0.15 | ||
| Q4 24 | $-0.44 | $-15.29 | ||
| Q3 24 | $-0.22 | $-18.24 | ||
| Q2 24 | $-0.64 | $-71.81 | ||
| Q1 24 | $-0.29 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $279.5M | $48.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.3M | $-249.4M |
| 总资产 | $784.1M | $308.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PACBSTEM
| Q4 25 | $279.5M | $48.9M | ||
| Q3 25 | $298.7M | $43.1M | ||
| Q2 25 | $314.7M | $40.8M | ||
| Q1 25 | $343.1M | $58.6M | ||
| Q4 24 | $389.9M | $56.3M | ||
| Q3 24 | $471.1M | $75.4M | ||
| Q2 24 | $509.8M | $89.6M | ||
| Q1 24 | $561.9M | $112.8M |
股东权益PACBSTEM
| Q4 25 | $5.3M | $-249.4M | ||
| Q3 25 | $36.1M | $-235.7M | ||
| Q2 25 | $61.5M | $-214.1M | ||
| Q1 25 | $91.6M | $-417.5M | ||
| Q4 24 | $506.6M | $-398.4M | ||
| Q3 24 | $453.1M | $-344.1M | ||
| Q2 24 | $492.7M | $-203.2M | ||
| Q1 24 | $649.0M | $371.6M |
总资产PACBSTEM
| Q4 25 | $784.1M | $308.9M | ||
| Q3 25 | $803.2M | $362.6M | ||
| Q2 25 | $825.5M | $379.2M | ||
| Q1 25 | $860.8M | $405.1M | ||
| Q4 24 | $1.3B | $437.4M | ||
| Q3 24 | $1.5B | $537.8M | ||
| Q2 24 | $1.5B | $691.5M | ||
| Q1 24 | $1.7B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.1M | $8.2M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | — |
| 自由现金流率自由现金流/营收 | -44.6% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-114.1M | — |
8季度趋势，按日历期对齐
经营现金流PACBSTEM
| Q4 25 | $-19.1M | $8.2M | ||
| Q3 25 | $-18.7M | $11.4M | ||
| Q2 25 | $-29.4M | $-21.3M | ||
| Q1 25 | $-44.1M | $8.5M | ||
| Q4 24 | $-30.6M | $-14.7M | ||
| Q3 24 | $-45.5M | $-9.4M | ||
| Q2 24 | $-54.3M | $-11.9M | ||
| Q1 24 | $-75.7M | $-621.0K |
自由现金流PACBSTEM
| Q4 25 | $-19.9M | — | ||
| Q3 25 | $-18.8M | — | ||
| Q2 25 | $-29.9M | — | ||
| Q1 25 | $-45.4M | — | ||
| Q4 24 | $-32.3M | — | ||
| Q3 24 | $-46.3M | — | ||
| Q2 24 | $-55.7M | — | ||
| Q1 24 | $-79.6M | — |
自由现金流率PACBSTEM
| Q4 25 | -44.6% | — | ||
| Q3 25 | -48.9% | — | ||
| Q2 25 | -75.3% | — | ||
| Q1 25 | -122.3% | — | ||
| Q4 24 | -82.3% | — | ||
| Q3 24 | -115.7% | — | ||
| Q2 24 | -154.8% | — | ||
| Q1 24 | -205.0% | — |
资本支出强度PACBSTEM
| Q4 25 | 1.9% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 4.1% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 4.1% | — | ||
| Q1 24 | 10.0% | — |
现金转化率PACBSTEM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | -12.93× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
STEM
暂无分部数据
